Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edwin P. Alyea
Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Immune-Related Fulminant Myocarditis in a Patient Receiving Ipilimumab Therapy for Relapsed Chronic Myelomonocytic Leukaemia
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia With Cyclophosphamide in Combination With Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Dynamics of Immune Cell Reconstitution in Allogeneic Hematopoietic Cell Transplant Patients Receiving Post-Transplant Cyclophosphamide (PTCy)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan With Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem-Cell Transplantation in the Modern Era: A Cohort Analysis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Impact of Anti- T Lymphocyte Globulin (ATLG) on Immune Reconstitution in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT): Results From a Prospective Randomized Double Blind Phase 3 Clinical Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Improved Overall Survival in Patients With Grade III and IV Acute Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
1
2
›
